Literature DB >> 25002726

Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments.

Susan E Krown1, Margaret Z Borok2, Thomas B Campbell3, Corey Casper4, Dirk P Dittmer5, Mina C Hosseinipour6, Ronald T Mitsuyasu7, Anisa Mosam8, Jackson Orem9, Warren T Phipps10.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25002726      PMCID: PMC4809749          DOI: 10.1200/JCO.2014.55.8999

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  12 in total

1.  Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi.

Authors:  Rony Zachariah; Margaret Fitzgerald; Moses Massaquoi; Olesu Pasulani; Line Arnould; Simon Makombe; Anthony D Harries
Journal:  AIDS       Date:  2006-11-28       Impact factor: 4.177

2.  HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma.

Authors:  Roberta Mancuso; Renato Biffi; Marilena Valli; Monica Bellinvia; Athanasia Tourlaki; Tourlaki Athanasia; Silvia Ferrucci; Lucia Brambilla; Serena Delbue; Pasquale Ferrante; Carmine Tinelli; Mario Clerici
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

3.  Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.

Authors:  Soren Gantt; Abel Kakuru; Anna Wald; Victoria Walusansa; Lawrence Corey; Corey Casper; Jackson Orem
Journal:  Pediatr Blood Cancer       Date:  2010-05       Impact factor: 3.167

4.  Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.

Authors:  Margaret Borok; Suzanne Fiorillo; Ivy Gudza; Beverly Putnam; Buxton Ndemera; Irene E White; Lovemore Gwanzura; Robert T Schooley; Thomas B Campbell
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

Review 5.  Modern evolutionary history of the human KSHV genome.

Authors:  G S Hayward; J C Zong
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

Review 6.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Xavier Anglaret; Landon Myer; Robin Wood
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

7.  Study of human herpesvirus 8 (HHV-8) variants from Kaposi's sarcoma in France: is HHV-8 subtype A responsible for more agressive tumors?

Authors:  F Boralevi; B Masquelier; M Denayrolles; M Dupon; J L Pellegrin; J M Ragnaud; H J Fleury
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

8.  Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.

Authors:  Barbara Castelnuovo; Yukari C Manabe; Agnes Kiragga; Moses Kamya; Philippa Easterbrook; Andrew Kambugu
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

9.  Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.

Authors:  Mark Bower; Alessia Dalla Pria; Chris Coyle; Eileen Andrews; Victoria Tittle; Sharanjit Dhoot; Mark Nelson
Journal:  J Clin Oncol       Date:  2013-12-30       Impact factor: 44.544

10.  Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma.

Authors:  Jonathan Krell; Justin Stebbing
Journal:  J Clin Oncol       Date:  2013-12-30       Impact factor: 44.544

View more
  5 in total

Review 1.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

2.  Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.

Authors:  Rachel A Bender Ignacio; Jeannette Y Lee; Michelle A Rudek; Dirk P Dittmer; Richard F Ambinder; Susan E Krown
Journal:  J Acquir Immune Defic Syndr       Date:  2016-05-01       Impact factor: 3.731

Review 3.  Diagnosis and Treatment of Kaposi Sarcoma.

Authors:  Johann W Schneider; Dirk P Dittmer
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

Review 4.  Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives.

Authors:  Nader Kim El-Mallawany; Casey L McAtee; Liane R Campbell; Peter N Kazembe
Journal:  Pediatric Health Med Ther       Date:  2018-04-19

5.  Effectiveness and Safety of Treatment with Neodymium:YAG Laser 1064 nm in Patients with Classic and Epidemic Kaposi Sarcoma.

Authors:  Martina Silvestri; Alessandra Latini; Ilaria Lesnoni La Parola; Claudia Messina; Steven Paul Nisticò; Norma Cameli
Journal:  Bioengineering (Basel)       Date:  2022-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.